Aprea Therapeutics, Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Aprea Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q4 2022.
  • Aprea Therapeutics, Inc. Operating Lease, Payments for the quarter ending December 31, 2022 was $53.4K, a 16.6% decline year-over-year.
  • Aprea Therapeutics, Inc. Operating Lease, Payments for the twelve months ending December 31, 2022 was $246K, a 3.72% decline year-over-year.
  • Aprea Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $246K, a 3.72% decline from 2021.
  • Aprea Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $255K, a 1.37% increase from 2020.
  • Aprea Therapeutics, Inc. annual Operating Lease, Payments for 2020 was $252K, a 43.9% increase from 2019.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $246K $53.4K -$10.6K -16.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 $256K $64.1K $0 0% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $256K $64.1K +$575 +0.91% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $256K $64.1K +$574 +0.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $255K $64.1K +$1.15K +1.83% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-26
Q3 2021 $254K $64.1K +$1.15K +1.82% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $253K $63.5K +$573 +0.91% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $252K $63.5K +$573 +0.91% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $252K $62.9K +$275 +0.44% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-30
Q3 2020 $251K $62.9K +$11.5K +22.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $240K $62.9K +$32.5K +107% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $207K $62.9K +$32.5K +107% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $175K $62.6K Oct 1, 2019 Dec 31, 2019 10-K 2022-03-15
Q3 2019 $51.4K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $30.4K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 $30.4K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.